Sahpra ends use of Ivermectin for Covid-19 treatment in SA
South African Health Products Regulatory Authority (Sahpra) CEO Dr Boitumelo Semete announced on Monday the termination of the use of the Ivermectin drug for the treatment and prevention of Covid-19 in South Africa.
The drug received significant worldwide public interest in 2020 as having some potential benefit in the management of Covid-19.
The Sahpra said that there was currently no credible evidence to support a therapeutic role for Ivermectin in Covid-19.
Unregistered Ivermectin products will not be allowed to be imported and health facilities will not be allowed to hold bulk stock in anticipation of prescriptions for such unregistered Ivermectin products.
However, prescribers are still expected to report on the clinical outcomes of those patients for whom treatment approval was given prior.
“Permission was granted to five importers of unregistered Ivermectin oral solid dosage forms, and health facilities were enabled to hold bulk stock, in anticipation of patient need. Individual named patient applications were still required, after prescribers had initiated use of Ivermectin. Sahpra also undertook to monitor the emerging evidence of safety and efficacy, for both treatment and prevention,” said Semete.
She added that although there had been several developments in Ivermectin efficacy, Covid-19 vaccines are now widely available.
The Sahpra has noted a decline in the number of health facilities applying for permission to hold bulk stock of Ivermectin since August 2021.
Sahpra said it would continue to monitor the peer-reviewed, scientific literature regarding the safety and efficacy of Ivermectin.
Article Enquiry
Email Article
Save Article
Feedback
To advertise email advertising@creamermedia.co.za or click here
Research Reports
Projects
Latest Multimedia
Latest News
Showroom
M and J Mining are leading suppliers of physical support systems as used by the underground mining industry. Our selection of products are not...
VISIT SHOWROOM
Astore Keymak is one of South Africa’s leading suppliers of high-quality Thermoplastic Pipeline Systems, with branches in the major provinces.
VISIT SHOWROOM
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation
